(Q55043389)

English

Increasing evidence that the risks of rhAPC may outweigh its benefits.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

0 references

Increasing evidence that the risks of rhAPC may outweigh its benefits. (English)

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

author name string

Peter Q Eichacker

1

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

Charles Natanson

2

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

publication date

15 February 2007

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

Intensive Care Medicine

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

33

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

3

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

396-399

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

https://scigraph.springernature.com/pub.10.1007/s00134-007-0556-8

0 references

The value of phase 4 clinical testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First, gather the data

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substantiating the concerns about recombinant human activated protein C use in sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

1 reference

https://pubmed.ncbi.nlm.nih.gov/17325833

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00134-007-0556-8

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/MED/17325833

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55043389&oldid=1644752128"